Minimizing toxicity in drug design involves several strategies:
Structure-Activity Relationship (SAR) Studies: Modifying the chemical structure to enhance safety. Prodrug Design: Developing inactive compounds that become active only in specific tissues. Targeted Drug Delivery: Designing drugs that specifically target diseased cells, minimizing exposure to healthy cells. Biomarker Identification: Using biomarkers to predict and monitor adverse effects.
